TradingView
DiastoAle
Apr 5, 2022 11:55 AM
Missed Approval But Q2 Looks Promsing
Long
NASDAQ:UTHR
1D
United Therapeutics Corporation
NASDAQ
Description
⋅
Apr 5, 2022 11:55 AM
More things down the pipeline to come, and this company is making tons of money. This price is going to fill the gap for sure and stay above 200 in Q2.
Trend Analysis
More